研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

成人星形细胞肿瘤中的细胞外基质结构及其与免疫细胞的相互作用。

Extracellular Matrix Structure and Interaction with Immune Cells in Adult Astrocytic Tumors.

发表日期:2024 Jul 05
作者: Anna Di Vito, Annalidia Donato, Jessica Bria, Francesco Conforti, Domenico La Torre, Natalia Malara, Giuseppe Donato
来源: Brain Structure & Function

摘要:

细胞外基质(ECM)是由胚胎和成人的正常和病理组织的细胞成分产生的一组动态分子。 ECM 在分化、细胞增殖、血管生成和免疫控制等各种生物过程中发挥着关键调节作用。最常见的原发性脑肿瘤是神经胶质瘤,迄今为止大多数是成人星形细胞瘤(AAT)。这些肿瘤患者的预后很差,治疗可以适度提高生存率。文献中关于AAT中ECM成分的研究较多,而将ECM成分与免疫调节相关的研究较少。循环 ECM 蛋白已成为一种有前途的生物标志物,它反映了肿瘤微环境的一般免疫状况,并可能代表评估疾病活动性的有用工具。鉴于其对治疗和预后目的的重要性,我们研究的目的是总结 ECM 成分的生物学特性及其对肿瘤微环境的影响,并概述主要 ECM 蛋白与 AAT 中免疫细胞之间的相互作用。随着神经胶质瘤免疫治疗领域的迅速扩展,我们保留当前数据以及未来对神经胶质瘤 ECM 组织和功能的研究将为调整免疫治疗方法提供重要见解。© 2024。作者。
The extracellular matrix (ECM) is a dynamic set of molecules produced by the cellular component of normal and pathological tissues of the embryo and adult. ECM acts as critical regulator in various biological processes such as differentiation, cell proliferation, angiogenesis, and immune control. The most frequent primary brain tumors are gliomas and by far the majority are adult astrocytic tumors (AATs). The prognosis for patients with these neoplasms is poor and the treatments modestly improves survival. In the literature, there is a fair number of studies concerning the composition of the ECM in AATs, while the number of studies relating the composition of the ECM with the immune regulation is smaller. Circulating ECM proteins have emerged as a promising biomarker that reflect the general immune landscape of tumor microenvironment and may represent a useful tool in assessing disease activity. Given the importance it can have for therapeutic and prognostic purposes, the aim of our study is to summarize the biological properties of ECM components and their effects on the tumor microenvironment and to provide an overview of the interactions between major ECM proteins and immune cells in AATs. As the field of immunotherapy in glioma is quickly expanding, we retain that current data together with future studies on ECM organization and functions in glioma will provide important insights into the tuning of immunotherapeutic approaches.© 2024. The Author(s).